Medpace Holdings, Inc. (MEDP)

Services-Commercial Physical & Biological Research

Latest Price

$624.18

TTM P/E

36.63

Normalized P/E

54.99

Div Yield

Book Value

15.19

P/B Ratio

41.09

Valuation metrics

EPS: $15.28

Book value / share: $16.18

Formula: √(22.5 × EPS × BVPS)

Graham Number

$74.59

88% downside

Norm. op. income: $279M (median of 7yr)

Tax rate: 15%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$100.99

84% downside

Base FCF: $397M (median of recent 5yr)

Growth: 21%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$817.48

+31% upside

EPS: $15.28

Target P/E: 55×

Formula: EPS × P/E

P/E Fair Value

$840.40

+35% upside

85.7% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	2.50M	$1.32B	8.95%	+27.8K	2026-06-30
Price T Rowe Associates Inc	2.07M	$1.10B	7.42%	+1.78M	2026-06-30
AQR Capital Management LLC	1.28M	$677.0M	4.58%	-74.9K	2026-06-30
Vanguard Portfolio Management LLC	1.13M	$600.0M	4.06%	+11.7K	2026-06-30
Vanguard Capital Management LLC	1.03M	$543.0M	3.68%	+15.7K	2026-06-30
State Street Corp	710.9K	$376.0M	2.55%	+28.7K	2026-06-30
Geode Capital Management, LLC	710.5K	$376.0M	2.55%	-34.6K	2026-06-30
Wasatch Advisors LP	636.6K	$337.0M	2.28%	-137.3K	2026-06-30
Invesco Ltd.	579.2K	$306.0M	2.08%	+1.7K	2026-06-30
Baillie Gifford & Co	473.2K	$250.0M	1.70%	-30.0K	2026-06-30